A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis
Open-Label Compassionate Use of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
Sponsor: Romark Laboratories L.C.
A NA clinical study on Cryptosporidiosis and HIV Infections, this trial is ongoing. The trial is conducted by Romark Laboratories L.C. and has accumulated 5 data snapshots since 2026. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status NA
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Romark Laboratories L.C.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Tampa, United States